Synthetic Lethality Beyond BRCA: A Phase I Study of Rucaparib and Irinotecan in Metastatic Solid Tumors With Homologous Recombination-Deficiency Mutations Beyond BRCA1/2.

Saved in:
Bibliographic Details
Title: Synthetic Lethality Beyond BRCA: A Phase I Study of Rucaparib and Irinotecan in Metastatic Solid Tumors With Homologous Recombination-Deficiency Mutations Beyond BRCA1/2.
Authors: Tsang ES; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA., Dhawan MS; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA., Pacaud R; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA., Thomas S; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA., Grabowsky J; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA., Wilch L; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA., Karipineni S; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA., Kelley RK; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA., Ko AH; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA., Collisson E; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA., Chapman JS; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA., Ueda S; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA., Bergsland EK; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA., Munster P; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA.
Source: JCO precision oncology [JCO Precis Oncol] 2024 Jun; Vol. 8, pp. e2300494.
Publication Type: Journal Article; Clinical Trial, Phase I; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38865673
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Synthetic Lethality Beyond BRCA: A Phase I Study of Rucaparib and Irinotecan in Metastatic Solid Tumors With Homologous Recombination-Deficiency Mutations Beyond BRCA1/2.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Tsang+ES%22">Tsang ES</searchLink>; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Dhawan+MS%22">Dhawan MS</searchLink>; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Pacaud+R%22">Pacaud R</searchLink>; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Thomas+S%22">Thomas S</searchLink>; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Grabowsky+J%22">Grabowsky J</searchLink>; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Wilch+L%22">Wilch L</searchLink>; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Karipineni+S%22">Karipineni S</searchLink>; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Kelley+RK%22">Kelley RK</searchLink>; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Ko+AH%22">Ko AH</searchLink>; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Collisson+E%22">Collisson E</searchLink>; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Chapman+JS%22">Chapman JS</searchLink>; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Ueda+S%22">Ueda S</searchLink>; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Bergsland+EK%22">Bergsland EK</searchLink>; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Munster+P%22">Munster P</searchLink>; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101705370%22">JCO precision oncology</searchLink> [JCO Precis Oncol] 2024 Jun; Vol. 8, pp. e2300494.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase I; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Clinical+Oncology%22">American Society of Clinical Oncology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101705370 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-4284 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224734284%22">24734284 </searchLink><i>NLM ISO Abbreviation: </i>JCO Precis Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38865673
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1200/PO.23.00494
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e2300494
    Titles:
      – TitleFull: Synthetic Lethality Beyond BRCA: A Phase I Study of Rucaparib and Irinotecan in Metastatic Solid Tumors With Homologous Recombination-Deficiency Mutations Beyond BRCA1/2.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tsang ES
      – PersonEntity:
          Name:
            NameFull: Dhawan MS
      – PersonEntity:
          Name:
            NameFull: Pacaud R
      – PersonEntity:
          Name:
            NameFull: Thomas S
      – PersonEntity:
          Name:
            NameFull: Grabowsky J
      – PersonEntity:
          Name:
            NameFull: Wilch L
      – PersonEntity:
          Name:
            NameFull: Karipineni S
      – PersonEntity:
          Name:
            NameFull: Kelley RK
      – PersonEntity:
          Name:
            NameFull: Ko AH
      – PersonEntity:
          Name:
            NameFull: Collisson E
      – PersonEntity:
          Name:
            NameFull: Chapman JS
      – PersonEntity:
          Name:
            NameFull: Ueda S
      – PersonEntity:
          Name:
            NameFull: Bergsland EK
      – PersonEntity:
          Name:
            NameFull: Munster P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2024 Jun
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2473-4284
          Numbering:
            – Type: volume
              Value: 8
          Titles:
            – TitleFull: JCO precision oncology
              Type: main
ResultId 1